X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
male (20) 20
middle aged (15) 15
oncology (15) 15
aged (14) 14
treatment outcome (14) 14
female (13) 13
radiotherapy (13) 13
radiotherapy dosage (12) 12
adult (11) 11
index medicus (10) 10
cancer (8) 8
disease-free survival (7) 7
follow-up studies (7) 7
neoplasm staging (7) 7
radiology, nuclear medicine & medical imaging (7) 7
survival analysis (7) 7
brachytherapy - methods (6) 6
hungary (6) 6
prognosis (6) 6
prostatic neoplasms - radiotherapy (6) 6
aged, 80 and over (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
blasting (5) 5
carcinoma, squamous cell - radiotherapy (5) 5
chemotherapy, adjuvant (5) 5
combustion apparatus (5) 5
combustion processes (5) 5
consuming waste products by combustion (5) 5
cremation furnaces (5) 5
general tagging of cross-sectional technologies spanning over several sections of the ipc (5) 5
general tagging of new technological developments (5) 5
heating (5) 5
lighting (5) 5
mechanical engineering (5) 5
medicine & public health (5) 5
radiotherapy, adjuvant (5) 5
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (5) 5
surgery (5) 5
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (5) 5
technologies or applications for mitigation or adaptation againstclimate change (5) 5
weapons (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
clinical-practice guidelines (4) 4
combined modality therapy (4) 4
europe (4) 4
glioblastoma (4) 4
hematology (4) 4
immunotherapy (4) 4
paclitaxel (4) 4
palliative care (4) 4
prospective studies (4) 4
prostatic neoplasms - pathology (4) 4
quality assurance (4) 4
quality of health care (4) 4
radiation-sensitizing agents - pharmacology (4) 4
rituximab (4) 4
3122 cancers (3) 3
animals (3) 3
apoptosis (3) 3
audit (3) 3
brachytherapy - adverse effects (3) 3
cancer and oncology (3) 3
cancer centre (3) 3
cancer och onkologi (3) 3
cancer unit (3) 3
carcinoma, squamous cell - blood supply (3) 3
care and treatment (3) 3
care pathways (3) 3
cell line, tumor (3) 3
chemotherapy (3) 3
cyclophosphamide - administration & dosage (3) 3
delivery of health care - standards (3) 3
dose-response relationship, drug (3) 3
doxorubicin - administration & dosage (3) 3
drug administration schedule (3) 3
follow-up (3) 3
guidelines (3) 3
hdr brachytherapy (3) 3
hematology, oncology and palliative medicine (3) 3
immunohistochemistry (3) 3
kirurgi (3) 3
mice (3) 3
mice, scid (3) 3
multidisciplinary (3) 3
multidisciplinary team (3) 3
organisation of care (3) 3
patient-centred (3) 3
phase-ii (3) 3
prostate cancer (3) 3
prostatic neoplasms - diagnostic imaging (3) 3
quality (3) 3
radiation (3) 3
radiation therapy (3) 3
radiation-therapy (3) 3
radiotherapy planning, computer-assisted - methods (3) 3
rectal neoplasms - pathology (3) 3
rectal neoplasms - therapy (3) 3
retrospective studies (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Magyar onkologia, ISSN 0025-0244, 09/2017, Volume 61, Issue 3, p. 229
The majority of cancer patients becomes malnourished during the course of their disease. Malnutrition deteriorates the efficiency of all kinds of oncologic... 
Journal Article
Magyar onkologia, ISSN 0025-0244, 03/2017, Volume 61, Issue 1, p. 97
Radiation therapy traditionally plays a major role in the treatment of lymphoproliferative diseases. Diagnostics and treatment of these tumors improved... 
Journal Article
by Weller, Michael and Butowski, Nicholas and Tran, David D and Recht, Lawrence and Recht, Lawrence D and Lim, Michael and Hirte, Hal and Ashby, Lynn and Mechtler, Laszlo and Goldlust, Samuel and Goldlust, Samuel A and Iwamoto, Fabio and Drappatz, Jan and O'Rourke, James and O'Rourke, Donald M and Wong, Mark and Hamilton, Mark G and Hamilton, Mark and Finocchiaro, Gaetano and Perry, James and Wick, Wolfgang and Green, Jennifer and He, Yi and Turner, Christopher D and Yellin, Michael J and Keler, Tibor and Davis, Thomas A and Stupp, Roger and Sampson, John H and Campian, Jian and Becker, Kevin and Barnett, Gene and Nicholas, Garth and Desjardins, Annick and Benkers, Tara and Wagle, Naveed and Groves, Morris and Kesari, Santosh and Horvath, Zsolt and Merrell, Ryan and Curry, Richard and Schuster, David and Mrugala, Maciej and Jensen, Randy and Trusheim, John and Lesser, Glenn and Belanger, Karl and Sloan, Andrew and Purow, Benjamin and Fink, Karen and Raizer, Jeffrey and Schulder, Michael and Nair, Suresh and Peak, Scott and Brandes, Alba and Mohile, Nimish and Landolfi, Joseph and Olson, Jon and Jennens, Ross and DeSouza, Paul and Robinson, Bridget and Crittenden, Marka and Shih, Kent and Flowers, Alexandra and Ong, Shirley and Connelly, Jennifer and Hadjipanayis, Costas and Giglio, Pierre and Mott, Frank and Mathieu, David and Lessard, Nathalie and Sepulveda, Sanchez Juan and Lövey, József and Wheeler, Helen and Inglis, Po-Ling and Hardie, Claire and Bota, Daniela and Lesniak, Maciej and Portnow, Jana and Frankel, Bruce and Junck, Larry and Thompson, Reid and Berk, Lawrence and McGhie, John and Macdonald, David and Saran, Frank and Soffietti, Riccardo and Blumenthal, Deborah and André de, Sá Barreto Costa Marcos and Nowak, Anna and Singhal, Nimit and Hottinger, Andreas and Schmid, Andrea and Srkalovic, Gordan and Baskin, David and Fadul, Camilo and Nabors, Louis and LaRocca, Renato and Villano, John and Paleologos, Nina and ... and ACT IV Trial Investigators and ACT IV trial investigators
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. 1373 - 1385
Rindopepimut (also known as CDX-110), a vaccine targeting the deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet... 
GLIOMAS | ONCOLOGY | RECURSIVE PARTITIONING ANALYSIS | GROWTH-FACTOR | RADIOTHERAPY | CANCER | PEPTIDE | ADJUVANT TEMOZOLOMIDE | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Brain Neoplasms - pathology | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Dose-Response Relationship, Drug | Young Adult | Glioblastoma - genetics | Time Factors | Dacarbazine - analogs & derivatives | Adult | Female | Vaccines, Subunit - adverse effects | Brain Neoplasms - mortality | Dacarbazine - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Treatment Outcome | Brain Neoplasms - drug therapy | Disease-Free Survival | Internationality | Vaccines, Subunit - administration & dosage | Glioblastoma - pathology | Survival Analysis | Aged | Temozolomide | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Clinical trials | Care and treatment | Product development | Antineoplastic agents | Glioblastoma multiforme | Analysis
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 1/2008, Volume 184, Issue 1, pp. 1 - 7
Tumor-induced anemia often occurs in cancer patients, and is corrected by recombinant human erythropoietins (rHuEPOs). Recent studies indicated that, besides... 
Recombinant human erythropoietin alpha | Tumor-induced angiogenesis | Tumorinduzierte Angio genese | Oncology | Menschliches Plattenepithelkarzinom | Radiation therapy | Radiotherapy | Tumor xenograft model | Strahlentherapie | Medicine & Public Health | Rekombinantes menschliches Erythropoetin alpha | Menschliches Xenotransplantationsmodell | Human squamous cell carcinoma | OXYGENATION | RECEPTOR | HYPOXIA | tumor xenograft model | RADIATION-THERAPY | recombinant human erythropoietin alpha | human squamous cell carcinoma | III ESOPHAGEAL CANCER | tumor-induced angiogenesis | ONCOLOGY | radiation therapy | ENDOTHELIAL-CELLS | GROWTH | HEMOGLOBIN LEVELS | ANEMIA | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Erythropoietin - pharmacology | Neoplasm Transplantation | Tumor Stem Cell Assay | Apoptosis - drug effects | Apoptosis - radiation effects | Carcinoma, Squamous Cell - pathology | Humans | Radiation-Sensitizing Agents - pharmacology | Cell Division - radiation effects | Transplantation, Heterologous | Recombinant Proteins | Carcinoma, Squamous Cell - radiotherapy | Mice, SCID | Cell Division - drug effects | Animals | Soft Tissue Neoplasms - radiotherapy | Soft Tissue Neoplasms - pathology | Cell Line, Tumor | Female | Mice | In Vitro Techniques | Development and progression | Erythropoietin | Growth factors | Radiation | Tumors | Hypoxia | Cancer | Apoptosis
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 6/2014, Volume 190, Issue 6, pp. 602 - 603
Journal Article
Acta Histochemica, ISSN 0065-1281, 08/2019, Volume 121, Issue 6, pp. 680 - 689
Despite the success for the treatment of melanoma such as targeted molecular therapy, the use of such treatments are expensive For this reason, this study was... 
Melanoma second-line therapy | Tumor volume | Additive effects | Immunotherapy
Journal Article
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 06/2014, Volume 190, Issue 6, p. 602
Journal Article
Magyar onkologia, ISSN 0025-0244, 12/2017, Volume 61, Issue 4, p. 387
Pancreatic cancer has one of the worst outcomes among malignant tumors. At the time of diagnosis only 20% of the cases are resectable and 30-50% are locally... 
Journal Article
Magyar onkologia, ISSN 0025-0244, 03/2018, Volume 62, Issue 1, p. 62
Recently the prevalence of oligometastatic patients is increasing. A common site of distant spread is the liver. The standard of care is curative surgical... 
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 3/2006, Volume 182, Issue 3, pp. 149 - 156
Journal Article
Magyar onkologia, ISSN 0025-0244, 11/2016, Volume 60, Issue 4, p. 314
In this paper we present our early experience with a method for the management of respiratory motion in radiotherapy for early-stage lung cancer. Forty-six... 
Radiotherapy Dosage | Lung Neoplasms - mortality | Humans | Radiotherapy - methods | Lung Neoplasms - radiotherapy | Combined Modality Therapy | Neoplasm Staging
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 03/2004, Volume 67, Issue 1-2, pp. 147 - 157
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 02/2018, Volume 122, pp. 179 - 193
ECCO essential requirements for quality cancer care (ERQCC) are checklists and explanations of organisation and actions that are necessary to give high-quality... 
Organisation of care | Care pathways | Cancer unit | Europe | Health inequalities | Patient information | Healthcare system | Multidisciplinary team | Stomach cancer | Guidelines | Oesophageal cancer | Audit | Quality assurance | Essential requirements | Oesophageal-gastric cancer | Quality | Patient-centred | Gastric cancer | Cancer centre | Multidisciplinary | ESOPHAGOGASTRIC CANCER | GERIATRIC ASSESSMENT | FOLLOW-UP | HEMATOLOGY | PALLIATIVE CARE | DEDICATED MULTIDETECTOR CT | INTERNATIONAL SOCIETY | EUROPEAN-SOCIETY | GASTROINTESTINAL ENDOSCOPY ESGE | OF-LIFE | CLINICAL-PRACTICE GUIDELINES | ONCOLOGY | Delivery of Health Care - standards | Medical Oncology - methods | Delivery of Health Care - methods | Delivery of Health Care - organization & administration | Humans | Stomach Neoplasms - therapy | Medical Oncology - standards | Esophageal Neoplasms - therapy | Medical Oncology - organization & administration | Quality of Health Care | Esophageal cancer | esophagus tumor | oncology | Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi | Health Care Service and Management, Health Policy and Services and Health Economy | health care delivery | Esophageal Neoplasms | procedures | Stomach Neoplasms | human | organization and management | health care quality | standards | Medical Oncology | Delivery of Health Care | Cancer and Oncology | stomach tumor | Cancer och onkologi
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 02/2018, Volume 122, pp. 164 - 178
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.